The DECODE study : Diabetes epidemiology : collaborative analysis of diagnostic criteria in EuropeBALKAU, B.Diabetes & metabolism. 2000, Vol 26, Num 4, pp 282-286, issn 1262-3636Article

Diabetes mellitus, hyperglycaemia and cancerSIMON, D; BALKAU, B.Diabetes & metabolism. 2010, Vol 36, Num 3, pp 182-191, issn 1262-3636, 10 p.Article

Certification of cause of death in French diabetic patientsBALKAU, B; PAPOZ, L.Journal of epidemiology and community health (1979). 1992, Vol 46, Num 1, pp 63-65, issn 0143-005XArticle

Adherence measured by microtiter assay as a virulence marker for Staphylococcus epidermidis infectionsDEIGHTON, M. A; BALKAU, B.Journal of clinical microbiology (Print). 1990, Vol 28, Num 11, pp 2442-2447, issn 0095-1137, 6 p.Article

Insulin: in search of a syndromeFERRANNINI, E; BALKAU, B.Diabetic medicine. 2002, Vol 19, Num 9, pp 724-729, issn 0742-3071Article

Therapeutic inertiaBALKAU, B; HALIMI, S.Diabetes & metabolism. 2012, Vol 38, issn 1262-3636, 39 p., NS3Serial Issue

Epidemiological data on postprandial glycaemiaBALKAU, B; ESCHWEGE, E.Diabetes & metabolism. 2006, Vol 32, issn 1262-3636, 2S5-2S9, HS2Article

Risk factors and their identification. I: What is a risk factor ? = Les facteurs de risque et leur identification. I: Qu'est-ce qu'un facteur de risque ?BALKAU, B; ESCHWEGE, E.Diabète et métabolisme (Paris). 1995, Vol 21, Num 1, pp 69-75, issn 0338-1684Article

Risk factors and their identification. III: Examples = Les facteurs de risque et leur identification. III: ExemplesBALKAU, B; ESCHWEGE, E.Diabète et métabolisme (Paris). 1995, Vol 21, Num 4, pp 299-308, issn 0338-1684Article

Ischemic heart disease and alcohol-related causes of death : a view of the French paradoxBALKAU, B; ESCHWEGE, F; ESCHWEGE, E et al.Annals of epidemiology. 1997, Vol 7, Num 7, pp 490-497, issn 1047-2797Article

The frequency of alcoholisation among young people injured in accidents in FranceDELAUNAY, C; BALKAU, B; PAPOZ, L et al.Alcohol and alcoholism (Oxford). 1991, Vol 26, Num 4, pp 391-397, issn 0735-0414Article

Ursodiol for the long-term treatment of primary biliary cirrhosisPOUPON, R. E; POUPON, R; BALKAU, B et al.The New England journal of medicine. 1994, Vol 330, Num 19, pp 1342-1347, issn 0028-4793Article

DIABETIC RETINOPATHY IN NAURUANSKING H; BALKAU B; ZIMMET P et al.1983; AMERICAN JOURNAL OF EPIDEMIOLOGY; ISSN 0002-9262; USA; DA. 1983; VOL. 117; NO 6; PP. 659-667; BIBL. 16 REF.Article

Diabetes as a risk factor for sudden deathBALKAU, B; JOUVEN, X; DUCIMETIERE, P et al.Lancet (British edition). 1999, Vol 354, Num 9194, pp 1968-1969, issn 0140-6736Article

Risk factors and their identification. II: Study designs for identification of risk factors = Les facteurs de risque et leur identification. II: Méthodes d'identification des facteurs de risqueBALKAU, B; ESCHWEGE, E.Diabète et métabolisme (Paris). 1995, Vol 21, Num 3, pp 225-231, issn 0338-1684Conference Paper

Syndrome métabolique ou syndrome d'insulinorésustance. Données épidémiologiques récentes = Metabolic syndrome or insulinresistance syndrome. Recent epidemiological dataESCHWEGE, E; BALKAU, B.Annales d'endocrinologie. 2003, Vol 64, Num 3, pp 1S32-1S36, issn 0003-4266, SUPConference Paper

Therapeutic inertia in type 2 diabetes: insights from the PANORAMA study in FranceSIMON, D.Diabetes & metabolism. 2012, Vol 38, issn 1262-3636, S47-S52, NS3Article

A review of the metabolic syndromeBALKAU, B; VALENSI, P; ESCHWEGE, E et al.Diabetes & metabolism. 2007, Vol 33, Num 6, pp 405-413, issn 1262-3636, 9 p.Article

Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective StudyBALKAU, B; FORHAN, A; ESCHWEGE, E et al.Diabetologia (Berlin). 2002, Vol 45, Num 9, pp 1224-1230, issn 0012-186X, 7 p.Article

Case counting in epidemiology : Limitations of methods based on multiple data sourcesPAPOZ, L; BALKAU, B; LELLOUCH, J et al.International journal of epidemiology. 1996, Vol 25, Num 3, pp 474-478, issn 0300-5771Article

How to help the patient motivate himself?GRIMALDI, A.Diabetes & metabolism. 2012, Vol 38, issn 1262-3636, S59-S64, NS3Article

Discussion épidémiologique des nouveaux critères de diabète = Epidemiological debate about new criterions of diabetesBALKAU, B; CHARLES, M. A; ESCHWEGE, E et al.MTE. Médecine thérapeutique endocrinologie. 2000, Vol 2, Num 3, pp 229-234, issn 1295-9359Article

Is there a glycemic threshold for mortality risk ?BALKAU, B; BERTRAIS, S; DUCIMETIERE, P et al.Diabetes care. 1999, Vol 22, Num 5, pp 696-699, issn 0149-5992Article

European study of the certification and coding of causes of death of six clinical case histories of diabetic patientsBALKAU, B; JOUGLA, E; LAPOZ, L et al.International journal of epidemiology. 1993, Vol 22, Num 1, pp 116-126, issn 0300-5771Article

Selective forces and the maintenance of immunoglobulin polymorphismsPROPERT, D. N; BALKAU, B. J.Human biology. 1986, Vol 58, Num 1, pp 79-84, issn 0018-7143Article